Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin. [electronic resource]
Producer: 20051027Description: 186-92 p. digitalISSN:- 0009-3157
- Administration, Oral
- Adult
- Aged
- Anti-Bacterial Agents -- therapeutic use
- Community-Acquired Infections -- drug therapy
- Double-Blind Method
- Erythromycin -- pharmacology
- Female
- Humans
- Ketolides -- therapeutic use
- Male
- Middle Aged
- Penicillin Resistance
- Pneumonia, Pneumococcal -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.